Literature DB >> 1438796

Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution.

J Kötting1, N W Marschner, W Neumüller, C Unger, H Eibl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438796     DOI: 10.1159/000420838

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN: 0079-6263


× No keyword cloud information.
  14 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Intestinal absorption of miltefosine: contribution of passive paracellular transport.

Authors:  Cécile Ménez; Marion Buyse; Christophe Dugave; Robert Farinotti; Gillian Barratt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.

Authors:  Stefan R Vink; Jan H M Schellens; Wim J van Blitterswijk; Marcel Verheij
Journal:  Invest New Drugs       Date:  2005-08       Impact factor: 3.850

4.  Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.

Authors:  J Kötting; M R Berger; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  The phenyltetraene lysophospholipid analog PTE-ET-18-OMe as a fluorescent anisotropy probe of liquid ordered membrane domains (lipid rafts) and ceramide-rich membrane domains.

Authors:  Omar Bakht; Javier Delgado; Francisco Amat-Guerri; A Ulises Acuña; Erwin London
Journal:  Biochim Biophys Acta       Date:  2007-05-13

6.  Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.

Authors:  Cécile Ménez; Marion Buyse; Robert Farinotti; Gillian Barratt
Journal:  Lipids       Date:  2007-02-06       Impact factor: 1.880

7.  Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.

Authors:  Roberta Marino; Dana C Baiu; Saswati Bhattacharya; Benjamin Titz; Ellen Hebron; Bryan D Menapace; Sorabh Singhal; Jens C Eickhoff; Fotis Asimakopoulos; Jamey P Weichert; Mario Otto
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

8.  Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.

Authors:  P Kaufmann-Kolle; J Drevs; M R Berger; J Kötting; N Marschner; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Authors:  Steven E Fiester; Brock A Arivett; Amber C Beckett; Benjamin R Wagner; Emily J Ohneck; Robert E Schmidt; Jennifer T Grier; Luis A Actis
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

10.  Pharmacokinetics and biodistribution of Erufosine in nude mice--implications for combination with radiotherapy.

Authors:  Guido Henke; Lars H Lindner; Michael Vogeser; Hans-Jörg Eibl; Jürgen Wörner; Arndt C Müller; Michael Bamberg; Kirsten Wachholz; Claus Belka; Verena Jendrossek
Journal:  Radiat Oncol       Date:  2009-10-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.